Literature DB >> 7844622

Meningiomas of the cranial base.

R Desai1, J Bruce.   

Abstract

Treatment objectives for meningiomas of the cranial base include relief of neurologic disability and prevention of clinical progression or recurrence with the least morbidity. Recent advances in skull base surgical techniques, through an appreciation of skull base anatomy and institutional specialization, have contributed major improvements to the outlook for patients with these tumors, and previously inoperable cases may now often be removed completely with acceptable risk. Since significant morbidity may be incurred during surgical resection of these difficult lesions, especially in terms of cranial nerve dysfunction, the value of aggressive surgical resection must be weighted against the often indolent natural history of these lesions, and must be individualized in each patient. Completeness of resection is the major prognostic factor determining the outcome of patients with typical benign meningiomas in terms of length of survival, risk of recurrence, and neurological disability. Various means of prognosticating the growth potential of a given tumor are being investigated, though none have yet been confirmed for their predictive value in typical, histologically benign meningiomas. The role of external beam radiotherapy has not been subjected to adequately controlled, prospective studies, and there is currently insufficient followup to assess the risks and benefits of stereotactic radiosurgery. Advances in the clinical management of tumors of the skull base has had perhaps the greatest impact for patients with meningiomas who constitute a large portion of tumors seen in these locations. Although the majority have benign histological features, skull base meningiomas can present a formidable challenge due to their proximity to vital structures, surgical inaccessibility, and occasional aggressive features. The combination in recent years of advances in skull base surgical techniques, adjuvant therapy, and rehabilitation methods have dramatically improved the outcome for these tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7844622     DOI: 10.1007/bf01053043

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  136 in total

1.  MENINGIOMAS OF THE FORAMEN MAGNUM.

Authors:  B M STEIN; N E LEEDS; J M TAVERAS; J L POOL
Journal:  J Neurosurg       Date:  1963-09       Impact factor: 5.115

2.  The use of an intraluminal shunt for bypass grafts of the cavernous internal carotid artery. Technical note.

Authors:  T Hori; E Ikawa; A Takenobu; Y Anno; S Taniura; T Watanabe; Y Ueda
Journal:  J Neurosurg       Date:  1991-10       Impact factor: 5.115

3.  An extreme lateral approach to intradural lesions of the cervical spine and foramen magnum.

Authors:  C N Sen; L N Sekhar
Journal:  Neurosurgery       Date:  1990-08       Impact factor: 4.654

Review 4.  Meningiomas involving the clivus: a six-year experience with 41 patients.

Authors:  L N Sekhar; P J Jannetta; L E Burkhart; J E Janosky
Journal:  Neurosurgery       Date:  1990-11       Impact factor: 4.654

5.  The far lateral approach for ventrally placed foramen magnum and upper cervical spine tumours.

Authors:  G P Kratimenos; H A Crockard
Journal:  Br J Neurosurg       Date:  1993       Impact factor: 1.596

6.  Benign tumors of the foramen magnum.

Authors:  F B Meyer; M J Ebersold; D F Reese
Journal:  J Neurosurg       Date:  1984-07       Impact factor: 5.115

7.  Meningiomas of Meckel's cave.

Authors:  R Delfini; G Innocenzi; P Ciappetta; M Domenicucci; G Cantore
Journal:  Neurosurgery       Date:  1992-12       Impact factor: 4.654

8.  Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.

Authors:  G Di Chiro; J Hatazawa; D A Katz; H V Rizzoli; D J De Michele
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

9.  Incidental meningiomas in autopsy study.

Authors:  S Nakasu; A Hirano; T Shimura; J F Llena
Journal:  Surg Neurol       Date:  1987-04

10.  Experience with 36 surgical cases of petroclival meningiomas.

Authors:  M Samii; M Tatagiba
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

View more
  5 in total

1.  Levine-Sekhar grading system for prediction of the extent of resection of cranial base meningiomas revisited: study of 124 cases.

Authors:  Hooshang Saberi; Ali Tayebi Meybodi; Abdolreza Sheikh Rezai
Journal:  Neurosurg Rev       Date:  2006-01-11       Impact factor: 3.042

2.  Skull Base Meningiomas in Patients with Neurofibromatosis Type 2: An International Multicenter Study Evaluating Stereotactic Radiosurgery.

Authors:  Henry Ruiz-Garcia; Daniel M Trifiletti; Nasser Mohammed; Yi-Chieh Hung; Zhiyuan Xu; Tomas Chytka; Roman Liscak; Manjul Tripathi; David Arsanious; Christopher P Cifarelli; Marco Perez Caceres; David Mathieu; Herwin Speckter; Gautam U Mehta; Gregory P Lekovic; Jason P Sheehan
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-19

Review 3.  Treatment of meningioma: an update.

Authors:  Anthony L D'Ambrosio; Jeffrey N Bruce
Journal:  Curr Neurol Neurosci Rep       Date:  2003-05       Impact factor: 5.081

4.  Long-term evaluation of the effect of hypofractionated high-energy proton treatment of benign meningiomas by means of (11)C-L-methionine positron emission tomography.

Authors:  Mats Ryttlefors; Torsten Danfors; Francesco Latini; Anders Montelius; Erik Blomquist; Olafur Gudjonsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-28       Impact factor: 9.236

5.  Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.

Authors:  Reinhold Graf; Michail Plotkin; Ingo G Steffen; Reinhard Wurm; Peter Wust; Winfried Brenner; Volker Budach; Harun Badakhshi
Journal:  Head Face Med       Date:  2012-01-04       Impact factor: 2.151

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.